Common Contracts
5 similar null contracts by NeuroBo Pharmaceuticals, Inc., Kaival Brands Innovations Group, Inc.
PRE- FUNDED COMMON STOCK PURCHASE WARRANT KAIVAL BRANDS INNOVATIONS GROUP, INC.Kaival Brands Innovations Group, Inc. • June 25th, 2024 • Retail-nonstore retailers
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _______________________________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Kaival Brands Innovations Group, Inc., a Delaware corporation (the “Company”), up to _______________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). The Warrant shall initially be issued and maintained in the form of a security held in book entry form at the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a H
SERIES B COMMON STOCK PURCHASE WARRANT NeuroBo Pharmaceuticals, Inc.NeuroBo Pharmaceuticals, Inc. • June 25th, 2024 • Pharmaceutical preparations
THIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (the “Initial Exercise Date”), and on or prior to 5:00 p.m. (New York City time) on the earlier of (i) the five (5) years anniversary of the Stockholder Approval Date, and (ii) the six (6) months anniversary following the date on which the Company publicly announces the occurrence of the Series B Milestone Event; provided that, if such date is not a Trading Day, the immediately following Trading Day (the earlier of such dates, the “Termination Date”), but not thereafter, to subscribe for and purchase from NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. T
SERIES A COMMON STOCK PURCHASE WARRANT NeuroBo Pharmaceuticals, Inc.NeuroBo Pharmaceuticals, Inc. • June 25th, 2024 • Pharmaceutical preparations
THIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (the “Initial Exercise Date”), and on or prior to 5:00 p.m. (New York City time) on the earlier of (i) the twelve (12) months anniversary of the Stockholder Approval Date, and (ii) the 60th day following the date on which the Company publicly announces the occurrence of the Series A Milestone Event; provided that, if such date is not a Trading Day, the immediately following Trading Day (the earlier of such dates, the “Termination Date”), but not thereafter, to subscribe for and purchase from NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase pr
PRE-FUNDED COMMON STOCK PURCHASE WARRANT NeuroBo Pharmaceuticals, Inc.NeuroBo Pharmaceuticals, Inc. • June 25th, 2024 • Pharmaceutical preparations
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT NeuroBo Pharmaceuticals, Inc.NeuroBo Pharmaceuticals, Inc. • June 25th, 2024 • Pharmaceutical preparations
THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (the “Initial Exercise Date”), and on or prior to 5:00 p.m. (New York City time) on the earlier of (i) two (2) years after a resale registration statement covering the Warrant Shares (as such term is defined below) issuable upon the exercise of the Warrant hereunder becomes effective by the Commission, and (ii) June 23, 2029 (the earlier of such dates, the “Termination Date”), but not thereafter, to subscribe for and purchase from NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant sha
